Ocular Therapeutix (OCUL) Misses Q1 EPS by 9c

Ocular Therapeutix (NASDAQ: OCUL) reported Q1 EPS of ($0.40), $0.09 worse than the analyst estimate of ($0.31). Revenue for the quarter came in at $10.78 million versus the consensus estimate of $12.72 million.

For earnings history and earnings-related data on Ocular Therapeutix (OCUL) click here.

You May Also Be Interested In

• Science Applications Int'l (SAIC) Tops Q2 EPS by 70c
• Energy stocks rally as fresh U.S.-Iran attacks drive oil prices higher
• Stewart Information Services (STC) Raises Quarterly Dividend 4.8% to $0.55; 3.1% Yield